Author Archives: Marko

Is The Availability of Hepatitis C Drugs from India threatened?

Where does India come in in the pharmaceutical industry? This is how drug industry works. New drugs are being developed by big pharmaceutical corporations in the developed world (mostly the US and Europe). When such originator drugs are launched, they are usually very expensive and patients and healthcare insurances have to pay even 100s of dollars […]

A New Wave of Hepatitis C Patients Under the Age of 30 in the US

Hepatitis C is a disease that mostly affects people after 40 years of age. Being an asymptomatic disease, Hepatitis C virus (HCV) can be hiding in the liver for more than a decade without apparent effects. This gives us an indication about when Hepatitis C patients were infected – not in older age, but in […]

Example of a country where Hepatitis C spread is at an alarming rate – Pakistan

We have secured a viable cure for Hepatitis C with a sofosbuvir-based regimen. However, healing the existing patients is not enough. We also have to approach systematic treatment from another angle – reduce Hepatitis C spread. In the developed world, the newly discovered treatment is already taking effect and the number of Hepatitis C patients […]

Hepatitis C Burden and Distribution in Africa

The Hepatitis C virus (HCV) infects people all over the world but Africa is a special case. The virus causes a chronic liver disease and is among the leading factors of liver problems in the world. The statistics from the World Health Organisation (WHO) reveal that an estimated one hundred and seventy million people in […]

Hepatitis C History and Why Baby Boomers have the highest incidence of Hepatitis C infection

I just opened a textbook for medical students from 1980s, doing a research on Hepatitis C. Here's the interesting thing: When looking for liver diseases, in particular Hepatitis, the table of content only lists Hepatitis A and Hepatitis B. Where is Hepatitis C? "There are some evidence that another virus (Hepatitis C?) is present in […]

Is Zepatier cost low enough to drive down the Hepatitis C treatment prices?

Hepatitis C treatment prices are one of the most discussed issues in the medical world today. The patients want lower prices. The doctors have spoken against the high prices, and even the US Senate had a hearing about it. But the price of Hepatitis C treatment remained the same even almost 3 years after the first […]

Hepatitis C Drugs Insurance Coverage Practices investigated by NY attorney general

Insurance companies are a very important part of the lives of many Hepatitis C patients. With the effective new drugs costing up to $100,000, the majority of people are counting on their insurance companies to foot the bill. However, the staggering prices of Hepatitis C drugs present a crippling cost to many health insurance companies […]

Sunvepra (100mg asunaprevir) – A New Hepatitis C Drug for difficult-to-treat patients

The last two years or so have been very successful for Hepatitis C treatments. The revolutionary new line of drugs that was registered for chronic Hepatitis C since 2013 feature over 90% cure rates and a pill-per-day regimens. Asunaprevir is the latest drug that could provide an edge especially in patients who are difficult to […]

Hepatitis C Drugs may cost less than $100 to produce – Study by Dr. Andrew Hill

Even before Sovaldi, the first modern antiviral medicine for Hepatitis C, obtained FDA's market authorisation, a group of scientists from University of Liverpool correctly predicted the looming problem – Hepatitis C drugs will become one of the costliest and thus hardly accessible drugs on the planet. Dr. Andrew Hill and his team from the Department […]

Hep C treatment discount for US Army Veterans? Not even Bernie Sanders can stop Gilead’s extreme pricing

Here are some quick facts about Hepatitis C and US Army Veterans. Since 2013, we have a cure for Hepatitis C that is about 95% successful In the US, more than 200,000 Army Veterans suffer from Hepatitis C Here is what US Army Veterans are required to pay for the two of the most successful […]

× Chat